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c-FLIPIn this study, we show that atraxia telangiectasia mutated kinase (ATM) activity is generally upreg-
ulated by different apoptotic stimuli, i.e. TNF-a, TRAIL, paclitaxel, or UV. Apoptotic progression is
markedly attenuated by siATM-RNA through down regulation of caspase-8 and caspase-9 in parallel
with decreases in FLIP-S (short form of cellular FLICE inhibitory protein) protein levels and Bid
cleavage. In addition, ATM activity is upregulated through t-Cdc6 while caspase-8 and caspase-9
activities increase. Taken together, we suggest that ATM regulates caspase-8 activation by inﬂuenc-
ing levels of FLIP-S, ATM kinase activity is upregulated by t-Cdc6, and increased ATM activity plays an
essential role in the ampliﬁcation of apoptosis in TNF-a-stimulated HeLa cells.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction activated in response to double-stranded DNA breaks (DSBs) [8].DNA damage induced by ionizing radiation or other insults trig-
gers checkpoint activation and consequent cell cycle arrest, fol-
lowed by DNA repair or apoptosis. Disruption of cell cycle
checkpoint leads to increased genomic instability, which predis-
poses an organism to the development of cancer [1,2]. Accumulat-
ing data suggest that several members of the phosphatidylinositol
3-kinase related kinase (PIKK) family play pivotal role at the cell
cycle checkpoint in eukaryotic cells. The PIKK family members
share a COOH-terminal kinase domain bearing signiﬁcant se-
quence homology to the catalytic domains of mammalian and
yeast phosphoinositide 3-kinases (PI3K). ATM, ATR and DNA-PKs
belong to PI3K family [3]. ATM is a large protein; the genomic
DNA contains 66 exons resulting in an mRNA of approximately
12 kb that encodes a protein of approximately 350 kDa.
ATM is a proximal component of DNA damage-induced cell
cycle checkpoint pathways [4–7]. The kinase activity of ATM isATM is a serine–threonine protein kinase that undergoes auto-
phosphorylation at Ser 1981 after DNA damage to subsequently
initiate a signaling cascade that involves the phosphorylation of
several substrates [9]. Many ATM substrates are cell-cycle regula-
tor that play essential functions in the cellular response to DNA
damage and include p53, breast-cancer-associated 1 (BRCA1),
p53-binding protein 1 (53BP1) and the checkpoint kinase 2
(CHK2) [10–13].
There are accumulating evidences that ATM is also required in
apoptosis through regulation of proapoptotic proteins such as
Bid, p53/Bax. The BH3-only member Bid serves the unique function
of interconnecting the extrinsic death receptors for TNF-a and Fas
to the mitochondrial ampliﬁcation loop of the intrinsic pathway. In
a resting cell, Bid is predominantly cytoplasmic. Following TNF-a
or Fas treatment, Bid is cleaved by caspase-8 in an unstructured
loop [14]. Activated BH3-only proteins such as caspase-truncated
Bid (tBID) either directly or indirectly activate BAX and BAK, which
are required for the release of cytochrome c and the downstream
apoptotic program [15]. The BH3-only Bid protein partially local-
izes to the nucleus in healthy cells, is important for apoptosis in-
duced by DNA damage, and is phosphorylated following
induction of double-strand breaks in DNA. Bid phosphorylation is
mediated by the ATM kinase and occurs in mouse Bid on two
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checkpoint through phosphorylation by ATM upon DNA damage
[17].
TNF-a is a pleiotropic cytokine that regulates multiple cellular
responses, including inﬂammation and cell survival [18,19]. TNF-a
may promote a death signal through ligation of TNF receptors
(TNFR1 and TNFR2) and the recruitment of TNFR associated death
domain protein, Fas-associated death domain protein, and the ini-
tiator caspase-8. Activated caspase-8 may cleave caspase-3 directly
or may cleave the Bcl-2 family protein Bid [20,21], which targets
the mitochondria, inducing the loss of mitochondrial transmem-
brane potential (Wm), and release of proteins that initiate an addi-
tional death signal through the activation of caspase-9 [22,23].
There is evidence to suggests that mitochondria dysfunction has
an important role in TNF-a-induced apoptosis. Disruption of mito-
chondria plays a central role in TNF-a-induced apoptosis of macro-
phages following inhibition of NF-jB [24]. And then, TNF-related
apoptosis-inducing ligand-induced apoptosis of melanoma cells
is associated with changes in mitochondrial membrane potential
and perinuclear clustering of mitochondria [25].
A recent study shows that ATM is not only involved in DNA
damage induced apoptosis but also plays an essential role in death
receptor induced apoptosis. ATM deﬁciency results in a signiﬁcant
resistance of lymphoid cells derived from A-T patients to Fas-in-
duced apoptosis. Interestingly, loss of endogenous ATM kinase
activity results in the aberrant up-regulation of FLIP protein which
is well-known inhibitor of Fas-induced apoptosis. Consistently,
ATM kinase activation down-regulates FLIP protein levels provid-
ing a novel mechanism to modulate Fas sensitivity [26]. Another
study showed that inhibition of ATM kinase activity enhanced
TRAIL-mediated apoptosis through down-regulation of c-FLIP lev-
els in human melanoma cells [27]. These data show that ATM ki-
nase activity affects extrinsic death pathway through the
regulation of FLIP protein levels, but the regulation mechanism
and effect appears different for different cell types.
In our previous study, we showed that caspase-3 cleaves Cdc6,
producing truncated Cdc6, during etoposide or TNF-a-induced
apoptosis. ATM activation is induced by Cdc6 cleavage upon expo-
sure to TNF-a, TRAIL (induce death receptor-mediated apoptosis),
etoposide, or UV (induce DNA damage mediated apoptosis).
Furthermore, we showed that ATM activation induced p53/Bax
mediated mitochondria-dependent apoptosis [28]. However, the
mechanism underlying the activation of ATM during TNF-a-in-
duced apoptosis remained unclear.
Here, we hypothesize that ATM kinase activity is commonly in-
volved in both DNA damage-induced apoptosis and receptor-med-
iated apoptosis and ATM kinase activation is required for apoptotic
progression. The aim of the present study is to explore the mecha-
nism of ATM activation through t-Cdc6 induced DNA damage dur-
ing TNF-a mediated extrinsic death pathway in HeLa cells.
2. Materials and methods
2.1. Plasmids
Human Cdc6 cDNA was provided by R.S. Williams (University of
Texas, Southwestern Medical Center, Dallas, TX; GenBank/EMBL/
DDBJ accession No. NM 001254). To monitor mammalian expres-
sion, Cdc6 was inserted into the vector pCS2 + GFP by amplifying
full-length Cdc6 cDNA (encoding a.a 1–560), or p32-tCdc6 cDNA
(encoding a.a 1–290).
2.2. Cell culture, transfection and apoptotic induction
Human cervical carcinoma (HeLa) cells were maintained at
37 C and 5% CO2 as a monolayer culture in DMEM supplementedwith 10% (vol/vol) heat inactivated calf serum, 100 lg/ml1 strep-
tomycin, and 250 ng/ml1 amphotericin B. HeLa cells were trans-
fected in 35-mm dishes with the appropriate plasmids using
Polyfect according to the manufacturer’s instruction. For apoptotic
induction, cells were treated with 1 mJ/cm2 UVC, 80 nM Taxol,
43 lM TRAIL or 5 ng/ml TNF-a and 10 lg/ml cycloheximide. As
TNF-a alone had no effect on HeLa cell viability, protein synthesis
inhibitor cycloheximide was used together with TNF-a for the
induction of apoptosis in HeLa cells.
2.3. Immunoblot analysis and immunoprecipitation pull-down assay
HeLa cells expressing Cdc6 were collected and extracted in lysis
buffer (0.5% Triton X-100, 20 mM Tris, PH 7.5, 2 mM MgCl2, 1 mM
DTT, 1 mM EGTA, 25 mM NaF, 50 mM b-glycerophosphate, 1 mM
Na3VO4, 2 lg/ml leupeptin, 2 lg/ml pepstatin A, 1 lg/ml antipain,
and 100 lg/ml PMSF). Cell lysates were centrifuged at 12000 rpm
for 15 min 4 C, and the supernatants were collected. After adjust-
ing the protein concentration, proteins were resolved by SDS–PAGE
before Western blot analysis with appropriate antibodies. Mono-
clonal anti-ATM, monoclonal anti-GFP and polyclonal anti-PARP
antibodies were obtained from Santa Cruz Biotechnology. And
polyclonal anti-actin antibody was obtained from SIGMA. Poly-
clonal anti-procaspase 9, anti-Bid, anti-p53, anti-caspase-8, anti-
p-ATM and anti-FLIP antibodies were obtained from Cell Signaling
Biotechnology. Immune complexes were revealed using ECL Wes-
tern blotting detection reagents (Amersham Biotechnologies). For
immunoprecipitation reaction, ATM was precipitated from cell ly-
sates with an anti-ATM monoclonal antibody overnight at 4 C
with end-over-end mixing followed by incubation with protein A
agarose for 2 h at 4 C. Immunoprecipitates were separated from
supernatants by centrifugation and washed with lysis buffer.
Proteins were extracted from agarose beads by resuspension in
1 laemmli gel-loading buffer and resolved by SDS–PAGE.
2.4. RNA interference
siRNA duplexes for ATM, ATR, and the control nontargeting siR-
NA were purchased from Dharmacon. The ATM-speciﬁc siRNA se-
quence (i.e., sense strand) was UAUAUCACCUGUUUGUUAGUU.
5  105 HeLa cells in 35 mm dishes were transfected with a ﬁnal
concentration of 100 nM siRNA duplexes using Oligofectamine
(Invitrogen) according to the manufacturer’s instruction.
2.5. ATM kinase assay
ATM kinase was immunoprecipitated from HeLa cells, which
had been treated with various apoptosis inducing agents, using
anti-ATM polyclonal antibody in buffer (0.5% Triton X-100,
20 mM Tris, PH 7.5, 2 mM MgCl2, 1 mM DTT, 1 mM EGTA, 50 mM
b-glycerophosphate, 25 mMNaF, 1 mMNa3VO4, 2 lg/ml leupeptin,
2 lg/ml pepstatin A, 100 lg/ml PMSF, and 1 lg/ml antipain) fol-
lowed by incubation with protein A agarose at 4 C for 2 h. The
reactions for ATM activity were performed using 1 lg PHAS-1 (Cal-
biochem) as a substrate in reaction buffer (50 mM Tris, PH 7.5,
10 mMMgCl2, 1 mMDTT, 1 mM EGTA, 50 mM b-glycerophosphate,
25 mM NaF, 1 mM Na3VO4, 2 lg/ml leupeptin, 2 lg/ml pepstatin A,
100 lg/ml PMSF and 1 lg/ml antipain) containing immunoprecip-
itated ATM protein and 10 Ci c-[32p] ATP at 30 C for 30 min. The
reacted samples were suspended in SDS loading buffer, resolved by
SDS–PAGE and detected by autoradiography.
2.6. Fluorometric caspase-3 activity assay
50 lg of transfected cell lysates were incubated with 200 nM
Ac-DEVD-AMC (BD Biosciences) in reaction buffer (20 mM HEPES,
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37 C for 1 h. The reaction was monitored by ﬂuorescence emission
at 535 nm (excitation at 405 nm).
2.7. Fluorometric caspase-8 activity assay
50 lg of transfected cell lysates were incubated with 200 nM
Ac-IETD-AFC (BD Biosciences) in reaction buffer (20 mM HEPES,
PH 7.4, 100 mM NaCl, 10 mM DTT, 0.1% CHAPS and 10% sucrose)
at 37 C for 1 h. The reaction was monitored by ﬂuorescence emis-
sion at 460 nm (excitation at 405 nm).
3. Results
3.1. ATM kinase activity is commonly upregulated in both DNA
damage-induced and death receptor-mediated apoptosis
To assess if ATM kinase activity is commonly upregulated dur-
ing apoptotic progression, we examined the kinase activity in HeLa
cells during DNA damage-induced (1 mj/cm2 UVC or 80 nM Taxol)
(Fig. 1A) or death receptor-induced (TNF-a + CHX or TRAIL)
(Fig. 1B) apoptosis. The cells were harvested following treatments
for indicated times and the cell lysates were immunoprecipitated
with anti-ATM antibody and kinase assay was performed using
PHAS-1 as a substrate. The cell lysates were also subjected to
immunoblotting using anti-ATM antibody, anti-PARP antibody,
and anti-Actin antibody and subjected to caspase-3 activity assay.
The results showed that ATM kinase activity was commonly upreg-
ulated in parallel during apoptotic progression in all cases as indi-
cated by increases in PARP cleavage and caspase-3 activity. In
addition, ATM cleavage is observed following receptor mediated-
apoptotic inducer treatment (Fig. 1B). Thus, ATM activity was
upregulated during death receptor-mediated apoptosis as well as
DNA damage-induced apoptosis, which suggests that ATM kinase
activity is involved in extrinsic as well as intrinsic apoptosis
pathways.Fig. 1. ATM kinase activity is commonly upregulated in both of DNA damage-induced and
or 80 nM taxol for the indicated times, and cell extracts were subjected to immune-comp
PARP or Actin. Cell extracts were also used to measure caspase-3 activity using a ﬂuoresc
(error bars) from three determinations obtained in each of three experiments. (B) HeLa c
5 lg/ml cycloheximide (CHX) and cells were harvested to prepare cell lysates and ATM kin
perform the immune-complex kinase assay using PHAS-1 as a substrate. The cell lysat
corresponding antibodies.3.2. ATM kinase activity is functionally required for caspase-8
activation
Caspase-8 is well known as an initiator caspase, activated early
during TNF-a-induced apoptosis. To detect the relationship be-
tween ATM kinase activity and caspase-8 activity, we analyzed
the kinetics of ATM and caspase-8 activities. The results indicate
that ATM and caspase-8 activities are activated from 2 and 4 h after
treatment with TNF-a and reached a peak after 4 and 6 h, respec-
tively (Fig. 2A). These data indicate that ATM activation occurs ear-
lier than caspase-8 activation, thus suggesting that ATM activity
may be involved in caspase-8 activation in TNF-a-induced
apoptosis.
Previous studies have suggested that ATM activation is essential
for DNA damage-induced apoptosis. Therefore, we tested if ATM
kinase activity also is required for death receptor-mediated apop-
totic progression. We used siATM-RNA to more selectively block
ATM kinase activity in the cells. Our results indicate that the
expression of ATM (Fig. 2B) as well as its kinase activity are sub-
stantially blocked by siATM#2 during TNF-a-induced apoptosis
(Fig. 2D). Caspase-3 activity assay showed that TNF-a-induced
activation of caspase-3 activity was suppressed near 50% in
siATM-RNA transfected cells as compared to control siRNA trans-
fected cells (Fig. 2B). Collectively, these results show that ATM
kinase activity is involved in the activation of caspase-3 during
extrinsic apoptotic pathway.
It is well known that caspase-3 is activated downstream of cas-
pase-8 activation in the TNF-a-induced apoptosis. To explore if
caspase-3 activity inhibition upon knockdown of ATM is due to
the inhibition of caspase-8 activity or otherwise, we assayed for
caspase-8 activity. The results showed that caspase-8 activity is
down-regulated by ATM down-expression (Fig. 2C), which was
accompanied by increase of FLIP (S) levels detected by Western
blotting 24 h after siATM-RNA transfection in TNF-a treated HeLa
cells (Fig. 2E).death receptor-mediated apoptosis. (A) HeLa cells were treated with 1 mj/cm2 UVC
lex ATM kinase activity assay using PHAS-1 as a substrate, immunoblotting for ATM,
ence-labeled substrate as described in Section 2. Data are expressed as means ± S.D.
ells were treated for indicated time periods with 43 lM TRAIL or 5 ng/ml TNF-a and
ase was immunoprecipitated using a speciﬁc anti-ATM antibody from cell lysates to
es were also subjected to immunoblotting for ATM, PARP, FLIP-S and Actin using
Fig. 2. TNF-a-induced apoptosis is attenuated by down-expression of ATM. (A) HeLa cells were treated for indicated time periods with TNF-a and cycloheximide (CHX) and
cells were harvested to prepare cell lysates and ATM kinase was immunoprecipitated using a speciﬁc anti-ATM antibody from cell lysates to perform the immune-complex
kinase assay using PHAS-1 as a substrate. The cell lysates were also subjected to immunoblotting for PARP, and Actin using corresponding antibodies. Cell extracts were also
subjected to caspase-8 activity assays using a ﬂuorescence-labeled substrate, Ac-IETD-AFC. The activities were represented by RFU, relative ﬂuorescent unit. The means ± S.D.
(error bars) of data from at least three experiments are shown. (B) HeLa cells were transfected for 24 h with a ﬁnal concentration of 100 nM siCON-RNA for control, or three
sets of siATM-RNA (siATM #1, siATM #2 or siATM #1 and #2) and transfected cells were treated with TNF-a and cycloheximide (CHX) for 4 h. Cell extracts were resolved on
SDS–PAGE and analyzed by immunoblotting using anti-ATM and anti-Actin antibody. Cell extracts of siATM #2 transfected cells were subjected to assay for caspase-3 activity
as represented by RFU, relative ﬂuorescent unit. The means ± S.D. (error bars) of data from at least three experiments were shown. (C) Cell extracts were also subjected to
assay for caspase-8 activity using speciﬁc ﬂuorescence-labeled substrates, Ac-IETD-AFC. The caspases-8 activities were represented by RFU, relative ﬂuorescent unit. The
means ± S.D. (error bars) of data from at least three experiments are shown. (D) Cells were transfected with siATM #2 RNA and siCON RNA respectively, and cells were treated
with TNF-a and cycloheximide (CHX). Cells were harvested in indicated time after treatment and cell extracts were resolved on SDS–PAGE and analyzed by immunoblotting
using anti-p-ATM and anti-Actin antibody. (E) Cellular levels were detected by immunoblotting using anti-FLIP-S, anti-cleaved caspase 8 and anti-Actin antibody.
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co-treatment with siATM-RNA and caspase-8 inhibitor during TNF-a-
induced apoptosis
To ﬁnd supporting evidence, we tested whether TNF-a-induced
caspase-3 activity can be further down-regulated by blocking cas-
pase-8 activity under the same conditions. The results indicated
that cleavage of caspase-8 and PARP were partially or completely
inhibited by siATM-RNA transfection only or caspase-8 inhibitor
cotreatment (Fig. 3A). Consistent with the above data, caspase-8
and caspase-3 activity also was inhibited partially or completely
(Fig. 3B and C). Taken together, ATM kinase activity is likely di-
rectly involved in caspase-8 activation for amplifying caspase-3
activation during TNF-a-induced extrinsic apoptotic pathways.
3.4. Caspase-9 activities and Cdc6 cleavage were suppressed by ATM
down-expression during TNF-a-induced apoptosis
Interestingly, cleavage of Bid and procaspase-9 is delayed by
ATM down-expression (Fig. 4A). Collectively, these results sug-
gested that ATM kinase activity is possibly involved in both mito-
chondria-mediated and caspase-8-mediated pathway duringextrinsic apoptosis. We previously showed that Cdc6 is cleaved
by active caspase-3 during TNF-a-induced apoptosis and ATM is
activated by overexpression of t-Cdc6 [28]. However, the relation-
ship between Cdc6 and ATM in TNF-a induced apoptosis is not
clearly understood. For this, we investigated Cdc6 cleavage during
TNF-a induced apoptosis. Results showed that down-expression of
ATM by siATM RNA in HeLa cells also reduced cleavage of Cdc6
protein (Fig. 4B). In addition, we provide evidence that caspase-8
inhibitor pretreatment blocked the cleavage of Bid and procas-
pase-9 upon treatment with TNF-a plus CHX (Fig. 4C). Taken to-
gether, these results suggest that ATM can regulate tBid via the
activation of caspase-8 under these conditions.
3.5. Truncated Cdc6 (p32) upregulated caspase-8 activity through
ATM-mediated mitochondria ampliﬁcation process
To explore further the effect of t-Cdc6 (p32) in TNF-a-induced
apoptosis, HeLa cells were transfected with Cdc6-wt or t-Cdc6
and caspase-8 activity was evaluated. Results showed an increase
in ATM activity and cleavage of procaspase-9 upon t-Cdc6 overex-
pression (Fig. 5B). Most importantly, that the expression of FLIP-S
level was downregulated by t-Cdc6 overexpression (Fig. 5A).
Fig. 3. Cotreatment of siATM#2 RNA and Ac-IETD-FMK, caspase-8 inhibitor can further down-regulate caspase-3 activity to the level of uninduced cells during TNF-a-
induced apoptosis. Cells were transfected with siATM#2 RNA or siCON-RNA respectively and were treated for 4 h with TNF-a and cycloheximide (CHX) in the presence and
absence of 10 lM caspase-8 inhibitor, Ac-IETD-FMK. (A) Cell extracts were resolved on SDS–PAGE and analyzed by immunoblotting using anti-PARP, anti-cleaved caspase-8
and anti-Actin antibody. (B and C) Cell lysates were subjected to assays for caspase-8 and caspase-3 activity using speciﬁc ﬂuorescence-labeled substrates, Ac-IETD-AFC and
Ac-DEVD-AMC respectively. The caspase activities were represented by RFU, relative ﬂuorescent unit. The means ± S.D. (error bars) of data from at least three experiments are
shown.
Fig. 4. Activation of caspase-9 and cleavage of Cdc6 during TNF-a induced apoptosis. (A and B) Cells were transfected with siATM #2 RNA and siCON RNA respectively, and
cells were treated with TNF-a and cycloheximide (CHX). Cells were harvested in indicated time after treatment and cell extracts were resolved on SDS–PAGE and analyzed by
immunoblotting using anti-ATM, anti-procaspase-9, anti-Bid, anti-Cdc6 and anti-Actin antibody. Band densities were measured using a densitometer and represented as the
relative protein levels of Cdc6. (C) Cells were pretreated 10 lM caspase-8 inhibitor, Ac-IETD-FMK 1hour before TNF-a and cycloheximide (CHX) treatment. And then, cells
were harvested in indicated time after treatment and cell extracts were resolved on SDS–PAGE and analyzed by immunoblotting using anti-procaspase-9, anti-Bid and anti-
Actin antibody.
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sion (Fig. 5C and D). These results indicate that t-Cdc6 activates
caspase-8 and ATM kinase, which ampliﬁes apoptosis through
mitochondria mediated pathway.4. Discussion
ATM kinase, a DNA damage sensing kinase plays an important
role in DNA damage induced apoptosis. ATM kinase pathway
Fig. 5. Effect of Cdc6 cleavage on TNF-a-induced apoptosis (A and B) HeLa cells
were transfected with 4.5 lg pCS2 + GFP tagged Cdc6-wt or 3 lg tCdc6 (p32-tCdc6).
HeLa cell extracts were prepared at 48 h after transfection, and ATM kinase was
immunoprecipitated with anti-ATM antibody. ATM kinase activity was assayed in
in vitro with PHAS-1 as a substrate in the presence of c-[32P] ATP, resolved by 15%
SDS–PAGE, and followed by autoradiography. Proteins were also resolved by 8%
SDS–PAGE and subjected to immunoblot analysis with speciﬁc antibodies against
ATM, GFP, procaspase-9, FLIP-S and Actin. (C and D) Cell extracts were subjected to
assay for caspase-8 and caspase-3 activity using speciﬁc ﬂuorescence-labeled
substrates, Ac-IETD-AFC and Ac-DEVD-AMC respectively. The caspase activities
were represented by RFU, relative ﬂuorescent unit. The means ± S.D. (error bars) of
data from at least three experiments are shown.
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leading to the releases of cytochrome c and Smac proteins during
DNA damage-induced apoptosis. In our previous study, we found
that cleavage of Cdc6 induces up-regulation of ATM kinase activity
by a mechanism that is possibly associated with perturbation of
pre-RC complex formation leading to DNA damage signaling path-
way. In addition, Cdc6 cleavage-induced ATM kinase activity in-
volved in p53 mediated mitochondrial accumulation of Bax
leading to caspase-3 activation. ATM kinase activity is also up-reg-
ulated with similar cleavage kinetics of Cdc6 in HeLa cells during
TNF-a-induced apoptosis. Thus, we proposed a hypothesis that
truncated-Cdc6 (t-Cdc6) induced ATM kinase activity may be gen-
erally involved in mitochondria mediated pathway during intrinsic
as well as extrinsic apoptotic pathways. In this study, we provide
further evidence supporting this hypothesis.
In this paper, we describe a role for ATM in the regulation of
TNF-a-induced apoptosis. In particular, our ﬁndings point to
Cdc6 protein, as a key effecter of ATM activation in TNF-a-stimu-
lated HeLa cells. Importantly, the activation kinetics of ATM kinase
activities is consistent with those of Cdc6 cleavage in TNF-a-in-
duced apoptosis. Moreover, t-Cdc6 induced ATM activation con-
tributes to caspase-8 activation during TNF-a-induced apoptosis
for amplifying apoptotic progression.
As shown in Figs. 1 and 2, we found that ATM kinase activity is
commonly up-regulated during apoptotic cell death in cells in-
duced by two stimuli that induce DNA damage (treatment with
UV irradiation or Taxol) or by death receptor binding with TNF-a
or TRAIL. Moreover, activation kinetics of ATM kinase in all cases
occurs concurrently with caspase-3 activation. Thus, ATM kinase
activity is up-regulated with apoptotic progression in cells induced
by intrinsic as well as extrinsic pathways.
Furthermore, our results suggest that up-regulation of ATM ki-
nase activity is functionally required for apoptotic progression ofcells induced by TNF-a and CHX. Apoptotic progression is signiﬁ-
cantly inhibited when ATM activity is blocked by siATM-RNA trans-
fection and pharmacological inhibition of ATM (Fig. 2B and C,
Supplementary Fig. 1). Most importantly, ATM knockdown by
siATM-RNA directly suppresses caspase-8 activity through the
FLICE-inhibitory protein FLIP-S upregulation in TNF-a-induced
apoptosis (Fig. 2E). These ﬁndings are consistent with previously re-
ported data [26]. FLIP potently blocks death receptor mediated cell
death by interacting with caspase-8. Several splicing isoforms of
FLIPs have been reported, with the two most predominant translat-
ing into FLIP-L (55kD) and FLIP-S (26kD) proteins [29,30]. C-FLIP pro-
tein has dual functions. Several reports indicated that overexpression
of c-FLIP induces rather than inhibits apoptosis [31,32]. In contrast,
several studies provide evidence that c-FLIP is an inhibitor of death
receptor-mediated apoptosis [26,33]. Thus, subtle changes in intra-
cellular c-FLIP levels could determine the outcome of death recep-
tor-mediated signaling, resulting either in cell death or cell
survival. Our results showed that FLIP-S levels were maintained in
siATM-RNA transfected cellswhile FLIP-S levelswere decreased in si-
CON-RNA transfected cells during TNF-a induced apoptosis. More-
over, knock-down of FLIP by siFLIP-RNA can promote caspase-8
activation during TNF-a induced apoptosis in the Hela cells (Supple-
mentary Fig. 2). These data show that FLIP-S has an inhibitory effect
through inhibition of caspase-8 activity in our model system.
In addition, our results indicate that siATM not only directly
inhibits caspase-3 activity but also directly inhibit caspase-8 activ-
ity during TNF-a induced apoptosis. The hypothesis is further con-
ﬁrmed by caspase-8 activity assay (Fig. 3C). The results indicated
that cleavage of caspase-8 and PARP is partially or completely
inhibited by siATM RNA transfection alone or caspase-8 inhibitor
cotreatment (Fig. 3A). Furthermore, caspase-8 and caspase-3 activ-
ity are also inhibited partially or completely. In addition, caspase-8
inhibitor treatment alone also completely prevented the caspase-3
activation in siCON-RNA transfected cells (Fig. 3B and C). So, ATM
kinase activity is most likely directly involved in caspase-8 activa-
tion for amplifying caspase-3 activation during TNF-a-induced
extrinsic apoptotic pathway.
The ATM activation induced by TNF-a treatment, which occurs
earlier than caspase-mediated cleavage of PARP or caspase-3 acti-
vation, is likely a novel mechanism that promotes or accelerates
apoptotic progression during TNF-a-induced apoptosis (Fig. 2).
Interestingly, our data showed that cleavage of Cdc6 was delayed
by siATM RNA treatment in HeLa cells (Fig. 4B). And then, Cdc6
is cleaved by active caspase-3 in TNF-a-induced apoptosis and
truncated Cdc6 (p32) could induce caspase-8 activation through
ATM activation (Fig. 5B and C). These results suggest that there is
a feedback between Cdc6 protein and ATM kinase, which could
amplify TNF-a induced apoptosis in HeLa cells. From Fig. 5A, it is
clear that caspase-9 cleavage occurrs together with FLIP-S down-
regulation in t-Cdc6 overexpressed cells. Taken together, t-Cdc6
appears to play an important role in linking the intrinsic and
extrinsic death pathways during TNF-a-induced apoptosis.
T-Cdc6 ampliﬁed apoptotic progression through activation of ATM-
mediatedmitochondria death pathway and caspase-8 activation.
In summary, our work provides insights into a novel functional
role for ATM kinase during TNF-a-induced apoptosis in HeLa cells.
ATM is activated by TNF-a treatment and activated ATM up-regu-
lates caspase-8 activity through downregulation of FLIP protein.
This triggers caspase-3 activation at an early stage of apoptosis fol-
lowing TNF-a and CHX treatment. Cdc6 is cleaved by active cas-
pase-3 and t-Cdc6 is involved in ATM activity up-regulation,
which induces caspase-8 activation through down-regulation of
FLIP-S. Considering these ﬁndings together, we propose that ATM
kinase may play an important role as a mediator to link extrinsic
and intrinsic pathways for promoting apoptosis in TNF-a-induced
apoptosis.
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